Latest


Lupin launches generic gastric disorder tablets in US

  •   Mon, Nov 11 2013 05:11:07 PM

Mumbai, Nov 11 (IANS): Drug maker Lupin Monday said its US subsidiary Lupin Pharmaceuticals Inc has launched the generic version of Rabeprazole Sodium delayed-release tablet 20mg in the US market.

Lupin had earlier received final approval from the US regulator for the drug, indicated for the treatment of Gastroesophageal reflux disease (GERD).

Lupin's Rabeprazole Sodium delayed-release tablets, 20mg, are the generic equivalent of Eisai Inc.'s brand Aciphex, which clocked in $864 million in July 2012 - June 2013, as per IMS data.

Lupin has launched 11 products in the US market this year and received 15 approvals.
  

Top Stories


Leave a Comment

Title: Lupin launches generic gastric disorder tablets in US



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like